Andrew Fein

H.C. Wainwright Maintains Buy On BioCryst Pharmaceuticals, Inc. (BCRX) Following 1Q:16 Update

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares slipped yesterday 9% after the drug discovery company reported first-quarter results and update on its clinical progress.

Jason Cohen Jason Cohen — May 6, 2016, 7:53 AM EDT

H.C. Wainwright Reiterates Buy on Amarin Corporation plc (ADR) Following 1Q:16 Update

In a research report issued this morning, H.C.

Jason Cohen Jason Cohen — May 6, 2016, 7:33 AM EDT

H.C. Wainwright Pounds The Table On CytRx Corporation (CYTR)

H.C.

Jason Cohen Jason Cohen — April 22, 2016, 8:03 AM EDT

H.C. Wainwright Maintains Buy on ACADIA Pharmaceuticals Inc. Following Meeting with Management

In a research report issued yesterday, H.C.

Jason Cohen Jason Cohen — July 2, 2015, 4:08 PM EDT

H.C. Wainwright Maintains Buy on Celator Pharmaceuticals Inc Following Data from CPX-351 Study

H.C.

Scott Fields Scott Fields — June 26, 2015, 8:27 AM EDT

H.C. Wainwright Offers Commentary on OvaScience Inc Following ESHRE 2015

H.C.

Jason Cohen Jason Cohen — June 18, 2015, 9:38 AM EDT

Synthetic Biologics Inc (SYN) Continues To Remain Undervalued: H.C. Wainwright

In a research report released today, H.C.

Jason Cohen Jason Cohen — June 4, 2015, 11:15 AM EDT

H.C. Wainwright Initiates Buy on Invivo Therapeutics Holdings Corp; Sees 69% Upside For The Stock

In a research report released April 17, H.C.

Jason Cohen Jason Cohen — April 20, 2015, 4:37 PM EDT

H.C. Wainwright Reiterates Buy on Insmed Incorporated Following Analyst Day

H.C.

Jason Cohen Jason Cohen — March 26, 2015, 4:29 PM EDT

H.C. Wainwright Reiterates Bullish View On BioCryst Pharmaceuticals Following 4Q:14 Update

In a research report published Thursday, H.C.

Ben Mahaney, Editor — February 19, 2015, 5:05 PM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts